COVID-19

Outside of the loss of human life due to the COVID-19 pandemic, the past two years have greatly affected hospitals, health systems and the way providers deliver care. Healthcare executives are grappling with federal monetary assistance, growing burnout rates, workforce shortages and federal oversight of vaccines and testing. This channel is also designed to update clinicians on new research and guidelines regarding COVID patient treatment strategies and risk assessments.

PET imaging reveals long-term heart and lung damage from COVID-19
New data highlight the long-lasting effects of the coronavirus, revealing changes that are not detectable by standard medical assessments.
HHS, NIH announce new ‘universal’ vaccine standard for broad-spectrum protection
Currently in development, the “Generation Gold Standard” platform utilizes inert whole viruses to combat more strains of common illnesses, such as COVID and the flu. It’s on track for FDA approval in 2029.
HHS sued over RFK’s $11B cuts to infectious disease control
The Department of Health and Human Services is refusing to allocate funds meant to support state and local healthcare initiatives, as the money stemmed from now-defunct COVID-19 control efforts. A coalition of municipalities is suing to lift the block.
Owner of home healthcare company gets 14 months for defrauding COVID programs
Nakita Cannady, 49, was also convicted of defrauding Cigna to the tune of $194,000, billing the insurer for patient care hours her providers never filled.
Deaths after TAVR are on the rise: Is the pandemic to blame or should cardiologists be concerned?
COVID-19 may help explain the increased rates of cardiac and noncardiac mortality among TAVR patients, but there are several other factors to consider as well. Researchers explored nearly 11 years of STS/ACC registry data to learn more.

Dexamethasone improves outcomes for critically ill COVID-19 patients

Why dexamethasone could be a legitimate game-changer in the fight against COVID-19—and an update on the FDA and hydroxychloroquine.

Cleveland Clinic develops first risk prediction model for COVID-19 patients

Researchers at Cleveland Clinic have created the first risk prediction model that allows healthcare providers to find the likelihood of an individual patient testing positive for COVID—19, as well as possible outcomes from the virus.

Even mild myocardial injuries are a bad sign for COVID-19 patients

Researchers have found a link between myocardial injury and a higher risk of death among patients hospitalized in the United States for COVID-19.

First drug found to improve COVID-19 survival

A commonly known steroid drug has been found to greatly improve survival for COVID-19 patients. In fact, among severe patients, the steroid, Dexamethasone, reduced the number of deaths by one-third in a study conducted by the University of Oxford.

FDA says hydroxychloroquine unlikely to be effective in treating COVID-19

The FDA has revoked its emergency use authorization for hydroxychloroquine as a treatment for COVID-19 hospital patients, determining that the controversial drug was “unlikely to be effective in treating COVID-19.”

New payment model could save rural hospitals from a post-COVID collapse

The COVID-19 pandemic hit rural hospitals especially hard—and that’s bad news for patients in areas already associated with poor cardiovascular outcomes.

Honoring the nearly 600 US healthcare workers who have died from COVID-19

As the COVID-19 pandemic rages on, it is difficult to know just how many healthcare workers have lost their lives battling this deadly virus. According to a new project, the number currently sits at 586—and it is expected to continue rising.

Racial, gender disparities among heart transplant recipients with COVID-19

The researchers explored data from orthotopic heart transplant patients who were hospitalized for COVID-19 at one of two facilities.

COVID-19

PET imaging reveals long-term heart and lung damage from COVID-19

HHS, NIH announce new ‘universal’ vaccine standard for broad-spectrum protection

HHS sued over RFK’s $11B cuts to infectious disease control

Owner of home healthcare company gets 14 months for defrauding COVID programs

Deaths after TAVR are on the rise: Is the pandemic to blame or should cardiologists be concerned?